Another mTOR inhibitor, torkinib (PP242), was also treated with rapamycin (ABI-009), resulting in reduced tumor formation ability and aldehyde dehydrogenase 1 (ALDH1) activity, inducing autophagy [176]. Here, MTOR is linked to neoplasm.